Peterson Kristine
SEC-identified person · CIK 1508596 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arrivent Biopharma, Inc. AVBP | Director | filed 2024–2026 |
| Immunocore Holdings plc IMCR | Director | filed 2024–2026 |
| Enanta Pharmaceuticals INC ENTA | Director | filed 2017–2026 |
| Immunogen, Inc. IMGN | Director | filed 2012–2024 |
| Transcept Pharmaceuticals Inc TSPT | Director | filed 2016–2023 |
| Amarin Corp PLC\UK AMRN | Director | filed 2010–2022 |
| Psivida LTD PSDV | Director | filed 2017–2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.